Volume | 35 622 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,31 | Bas Haut |
|||||
Minimum Bas | 1,1345 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Alaunos Therapeutics Inc | TCRT | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,15 | 1,1345 | 1,31 | 1,16 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
193 | 35 622 | US$ 1,24 | US$ 44 314 | - | 0,66 - 10,47 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
21:27:53 | 1 | US$ 1,34 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
20,85M | 16,04M | - | 303k | -35,14M | -2,19 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Alaunos Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
29/2/2024 | 03:46 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
22/2/2024 | 22:44 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 18:43 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 22:58 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
29/1/2024 | 14:45 | Edgar (US Regulatory) | Form 8-K - Current report |
23/1/2024 | 23:47 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
22/1/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
03/1/2024 | 23:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
03/1/2024 | 23:25 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
02/1/2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
28/12/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Alaunos Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Alaunos Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,21 | 1,3399 | 0,98 | 1,15 | 34 826 | 0,09 | 7,44% |
1 mois | 1,81 | 1,89 | 0,98 | 1,52 | 51 456 | -0,51 | -28,18% |
3 mois | 2,01 | 2,60 | 0,98 | 1,89 | 82 672 | -0,71 | -35,32% |
6 mois | 1,4925 | 3,285 | 0,66 | 1,38 | 3 629 565 | -0,1925 | -12,90% |
1 an | 7,365 | 10,47 | 0,66 | 1,93 | 2 556 898 | -6,07 | -82,35% |
3 ans | 12,99 | 60,15 | 0,66 | 10,99 | 2 432 416 | -11,69 | -89,99% |
5 ans | 12,99 | 60,15 | 0,66 | 10,99 | 2 432 416 | -11,69 | -89,99% |